enVVeno Medical (NASDAQ:NVNO) reported quarterly losses of $(5.89) per share which missed the analyst consensus estimate of $(0.28) by 2003.57 percent. This is a 23.51 percent increase over losses of $(7.70) per share from the same period last year.